Properdin Deficiency and Increased Risk from Encapsulated Organisms

Role of Properdin in Complement Activation

• The Centers for Disease Control and Prevention recommends that properdin deficiency significantly increases susceptibility to encapsulated bacteria, particularly Neisseria meningitidis, by impairing the stabilization of C3 convertase on bacterial surfaces, which critically compromises the alternative pathway of complement activation and subsequent bacterial clearance 1, 2

Mechanism of Increased Susceptibility in Properdin Deficiency

Compromised Bacterial Recognition and Clearance

• Encapsulated bacteria like N. meningitidis rely heavily on alternative pathway activation for recognition and clearance, as stated by the American Academy of Pediatrics 1, 3
• The polysaccharide capsules of these organisms resist classical pathway activation, making the alternative pathway crucial for defense, according to the American Academy of Pediatrics 4

Impact on Opsonization and Bacterial Killing

• Higher antibody levels are needed for other clearance mechanisms (like opsonization) to function effectively in properdin-deficient individuals, as recommended by the Centers for Disease Control and Prevention 1

Clinical Significance and Manifestations

• N. meningitidis is the primary bacterial pathogen affecting persons with properdin deficiency, as reported by the Centers for Disease Control and Prevention 1, 2

Vaccination Considerations in Properdin Deficiency

• The Centers for Disease Control and Prevention recommends that persons with properdin deficiency should receive a 2-dose primary series of meningococcal conjugate vaccine administered 8-12 weeks apart 3, 4
• Booster doses should be administered every 5 years for those who received primary vaccination at age 7 years or older, as stated by the Centers for Disease Control and Prevention 3, 5
• Antibody titers wane more rapidly in persons with complement component deficiencies, necessitating more frequent booster doses, according to the Centers for Disease Control and Prevention 1, 5

Comparison with Other Complement Deficiencies

• While late complement component deficiencies (C5-C9) primarily affect the membrane attack complex formation, properdin deficiency specifically impairs the alternative pathway activation and C3b deposition, as reported by the American Academy of Pediatrics 1, 4